eFFECTOR Therapeutics, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q2 2020 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
eFFECTOR Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q2 2020 to Q1 2024.
  • eFFECTOR Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending March 31, 2024 was $1M, a 16.7% decline year-over-year.
  • eFFECTOR Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending March 31, 2024 was $4.4M, a 18.5% decline year-over-year.
  • eFFECTOR Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $4.6M, a 8% decline from 2022.
  • eFFECTOR Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $5M, a 400% increase from 2021.
  • eFFECTOR Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $1M, a 100% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $4.4M $1M -$200K -16.7% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $4.6M $1.1M -$300K -21.4% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-26
Q3 2023 $4.9M $1.1M -$500K -31.3% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $5.4M $1.2M $0 0% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $5.4M $1.2M +$400K +50% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $5M $1.4M +$1M +250% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-26
Q3 2022 $4M $1.6M +$1.4M +700% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 $2.6M $1.2M +$1M +500% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $1.6M $800K +$600K +300% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $1M $400K Oct 1, 2021 Dec 31, 2021 10-K 2023-03-08
Q3 2021 $200K $0 0% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 $200K +$100K +100% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $200K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q3 2020 $200K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-08
Q2 2020 $100K Apr 1, 2020 Jun 30, 2020 8-K 2021-08-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.